Andrade Paulo Henrique Santos, Santos Adriano da Silva, Souza Carlos Adriano Santos, Lobo Iza Maria Fraga, da Silva Wellington Barros
Laboratório de Ensino e Pesquisa em Farmácia Social (LEPFS), Departamento de Farmácia, Universidade Federal de Sergipe, Av. Marechal Rondon, S/n - Jardim Rosa Elze, São Cristóvão - SE, Brazil.
Universidade Federal de Sergipe, Aracaju, Sergipe, Brazil.
Ther Adv Drug Saf. 2017 Jun;8(6):199-210. doi: 10.1177/2042098617702615. Epub 2017 Apr 25.
The main objective of the present systematic review is to identify potential risk factors for adverse drug reactions (ADRs) through prospective cohort studies in pediatric inpatients.
The data search was done in the following electronic databases PubMed/MEDLINE; Scopus; LILACS and Web of Science from the earliest record until 31 May 2015. Two reviewers independently screened each study and one of them assessed the methodological quality according to the Newcastle-Ottawa scale for cohort studies. The data extraction was conducted according to Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) initiative for cohort studies.
The only risk factor observed in all studies was the increase in the number of prescription drugs. However, other factors were identified, such as the increase in the length of stay or the number of low- or high-risk drugs prescribed, use of general anesthesia and oncological diagnosis. The cumulative incidence of ADR was 16.4% (95% confidence interval: 15.6 to 17.2). The main professional responsible for ADR identification was the pharmacist and the dominant category among the ADRs were gastrointestinal disorders. In addition, analgesics, antibacterial agents and corticosteroids were the drug classes commonly associated with ADRs. The methodology used in this study was tried to homogenize the data extracted; however, this was not sufficient to correct the discrepancies so it was not possible to perform a meta-analysis.
The increase in the number of prescription drugs was the main risk factor in this population. However, additional studies are required to identify the risk factors for ADRs in pediatric inpatients.
本系统评价的主要目的是通过对儿科住院患者的前瞻性队列研究,确定药物不良反应(ADR)的潜在风险因素。
在以下电子数据库中进行数据检索:PubMed/MEDLINE、Scopus、LILACS和Web of Science,检索时间从最早记录至2015年5月31日。两名审阅者独立筛选每项研究,其中一人根据纽卡斯尔-渥太华队列研究量表评估方法学质量。根据加强流行病学观察性研究报告(STROBE)倡议进行队列研究的数据提取。
所有研究中观察到的唯一风险因素是处方药数量增加。然而,还确定了其他因素,如住院时间延长、低风险或高风险处方药数量增加、全身麻醉的使用和肿瘤诊断。ADR的累积发生率为16.4%(95%置信区间:15.6至17.2)。负责识别ADR的主要专业人员是药剂师,ADR中的主要类别是胃肠道疾病。此外,镇痛药、抗菌剂和皮质类固醇是与ADR常见相关的药物类别。本研究中使用的方法试图使提取的数据同质化;然而,这不足以纠正差异,因此无法进行荟萃分析。
处方药数量增加是该人群的主要风险因素。然而,需要进一步研究以确定儿科住院患者ADR的风险因素。